The field of clinical trials research in the Intensive Care environment has expanded significantly over the previous decade. The number of clinical trials being conducted in Australia and New Zealand has increased dramatically and commensurate with this, the complexity of the research projects has risen. In 1998 the pivotal role of Research Co-ordinators (RC) in managing the conduct of clinical trials in Intensive Care Units (ICUs) in Australia and New Zealand had gained increased recognition. It also became apparent that many RCs were working in isolation in this dynamic but ultimately stressful environment. Therefore, RCs often lacked the guidance and support, which can be offered by their peers.
In response to these concerns, a group of dedicated RCs from Australia and New Zealand, with the support of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG), formed the Intensive care Research Coordinators Interest Group (IRCIG). The IRCIG was formalised in March 2000 with its first meeting and the election of a committee.
The Intensive Care Research Coordinator Interest Group (IRCIG) is:
The specific aims of the IRCIG are to: